These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 3279646

  • 1. Quadruple immunosuppressive therapy for liver transplantation.
    Kalayoglu M, Stratta RJ, Hoffmann RM, Sollinger HW, Belzer FO.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):524-9. PubMed ID: 3279646
    [No Abstract] [Full Text] [Related]

  • 2. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 3. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 4. Experience with early quadruple immunosuppressive therapy in heart transplantation.
    Goenen M, Col J, Baele P, Latinne D, Noel H, Alexandre G, Schoevardts JC, Ponlot R, Chalant C.
    Bibl Cardiol; 1988 Feb; (43):23-6. PubMed ID: 3067718
    [No Abstract] [Full Text] [Related]

  • 5. The Stanford experience: survival and renal function in the pre-sandimmune era compared to the sandimmune era.
    Hunt SA, Gamberg P, Stinson EB, Oyer PE, Shumway NE.
    Transplant Proc; 1990 Jun; 22(3 Suppl 1):1-5. PubMed ID: 2349732
    [No Abstract] [Full Text] [Related]

  • 6. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 7. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP, Mendez-Picon G, King A, Nelson KP, Spicer HG, Lee HM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract] [Full Text] [Related]

  • 8. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 9. The role of antilymphocyte globulin in cadaver renal transplantation.
    Novick AC.
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
    [No Abstract] [Full Text] [Related]

  • 10. Clinical results of quadruple drug immunosuppression in liver transplantation.
    Fabregat J, Fradera R, Jaurrieta E, Figueras J, Rafecas A, Rufi G, Casanovas T, Casais L, Gil Vernet S.
    Transplant Proc; 1992 Feb; 24(1):148-9. PubMed ID: 1539217
    [No Abstract] [Full Text] [Related]

  • 11. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS, Alexander JL, Busch GJ, Murray JE.
    Surg Forum; 1969 Feb; 20():306-7. PubMed ID: 4192215
    [No Abstract] [Full Text] [Related]

  • 12. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
    Gruber SA, Chavers B, Payne WD, Fryd DS, Canafax DM, Simmons RL, Najarian JS, Matas A.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
    [No Abstract] [Full Text] [Related]

  • 13. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM, Bas J, Gonzalez C, Castelao AM, Seron D, Mestre M, Buendia E, Sabate R, Diaz C, Alsina J.
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract] [Full Text] [Related]

  • 14. Immunosuppression in cardiac transplantation.
    Rose EA, Addonizio LJ.
    Bibl Cardiol; 1988 Aug; (43):1-9. PubMed ID: 3067706
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM, Griñó JM, Sabaté I, Gilvernet S, Andres E, Sabater R, Alsina J.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract] [Full Text] [Related]

  • 16. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 17. Liver transplantation.
    Starzl TE.
    Z Gastroenterol; 1978 Dec; 16(12):725-38. PubMed ID: 369162
    [Abstract] [Full Text] [Related]

  • 18. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
    First MR, Alexander JW, Wadhwa N, Penn I, Munda R, Fidler JP, Weiskittel P.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
    [No Abstract] [Full Text] [Related]

  • 19. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM, Simmons RL, Sutherland DE, Fryd DS, Strand MH, Ascher NL, Payne WD, Najarian JS.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M, Latter DA, Loertscher R.
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.